Verano Holdings (VRNO) Other Non-Current Assets (2021 - 2026)
Verano Holdings' (VRNO) quarterly Other Non-Current Assets came in at $10.0 million in Q1 2026, down 24.69% year-on-year from $13.3 million in Q1 2025, and down 5.21% on a QoQ basis from $10.6 million in Q4 2025.
Verano Holdings (VRNO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Other Non-Current Assets data on file, last reported at $10.0 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 24.69% year-over-year to $10.0 million in Q1 2026; TTM through Mar 2026 was $10.0 million, a 24.69% decrease from a year earlier, with the FY2025 full-year figure at $10.6 million, down 20.76% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $10.0 million, down from $10.6 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for VRNO reached as high as $14.0 million in Q2 2025 and fell as low as $2.6 million in Q2 2022.
- Historically, Other Non-Current Assets has averaged $11.2 million across 5 years, with a median of $12.9 million in 2022.
- Across the five-year window, Other Non-Current Assets soared 422.31% in 2023 and declined 24.69% in 2026, its largest moves.
- Year by year, Other Non-Current Assets stood at $12.8 million in 2022, then fell by 3.27% to $12.3 million in 2023, then rose by 7.97% to $13.3 million in 2024, then declined by 20.76% to $10.6 million in 2025, then dropped by 5.21% to $10.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $10.0 million in Q1 2026, $10.6 million in Q4 2025, and $13.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.02 Mn |
| Dec 31, 2025 | 10.57 Mn |
| Sep 30, 2025 | 13.14 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 13.30 Mn |
| Dec 31, 2024 | 13.33 Mn |
| Sep 30, 2024 | 13.07 Mn |
| Jun 30, 2024 | 11.28 Mn |
| Mar 31, 2024 | 10.50 Mn |
| Dec 31, 2023 | 12.35 Mn |
| Sep 30, 2023 | 13.82 Mn |
| Jun 30, 2023 | 13.31 Mn |
| Mar 31, 2023 | 13.33 Mn |
| Dec 31, 2022 | 12.77 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Dec 31, 2021 | 2.50 Mn |